Investors for Opioid Accountability in the News

Read our recent press:

Pensions and Investments: Cardinal Health to disclose financial risks of opioid crisis; shareholder proposal withdrawn

STAT News: Under pressure from investors, Cardinal Helath agrees to bolster opioid oversight

Financial Times: Pharma investors mobilize on reputational risk concerns

CNBC: AmerisourceBergen could be the next victim of the opioid crisis, says Teamsters' general secretary-treasurer

Stat News: AmerisourceBergen shareholders reject proposal on managing opioid risks

Evening Standard: Aberdeen, Schroders and Hermes question US pharma giants over opioid abuse

Illinois Times: The pill pipeline: H.D. Smith under fire for opioid sales

Reuters: Investor group presses U.S. drug companies on opioid controls

London Evening Standard: Aberdeen, Schroders and Hermes question US pharma giants over opioid abuse

Stat News: Advisory firms back proposals requiring AmerisourceBergen to manage opioid risks

SNL: Catholic fund leads charge for stronger opioid controls at drugmakers, distributors

 

Press Releases:

Treasurer Magaziner: Shareholders Overwhelmingly Demand Action from Opioid Distributor after Company Fails to Block Vote at SEC

Independent Investors Support Shareholder Proposals on Opioids at AmerisourceBergen Shareholder Meeting

ISS, Glass Lewis Support Investors for Three Opioid Accountability Shareholder Proposals at AmerisourceBergen

Investors for Opioid Accountability/ IOA on Cardinal Health Annual Shareholder Meeting

$1.3 Trillion Investor Coalition Probes Pharma on Opioid Accountability

Faith investors back coalition to press opioid manufacturers and distributors for greater accountability

Sign Up for our eNewsletter

* indicates required